https://www.avient.com/industries/healthcare/catheter-materials-medical-tubing/medical-tubing
Personal Products
Personal Care Packaging
Also of Interest
https://www.avient.com/industries/healthcare/medical-packaging/nutraceutical-packaging
Personal Products
Personal Care Packaging
Also of Interest
https://www.avient.com/industries/healthcare/drug-delivery-systems/pump-technologies
Personal Products
Personal Care Packaging
Also of Interest
https://www.avient.com/industries/healthcare/medical-packaging/pharmaceutical-packaging
Personal Products
Personal Care Packaging
Also of Interest
https://www.avient.com/industries/healthcare/drug-delivery-systems/inhalation-devices
Personal Products
Personal Care Packaging
Also of Interest
https://www.avient.com/industries/consumer/consumer-discretionary/home-household/consumer-electronic-accessories
Personal Products
Personal Care Packaging
Also of Interest
https://www.avient.com/industries/consumer/consumer-discretionary/outdoor-recreation/shooting-sports
Personal Products
Personal Care Packaging
Also of Interest
https://www.avient.com/company/sustainability/sustainability-report/metrics/people-data-and-metrics
Total Fatality Rate (#—Direct)
Total Fatality Rate (#—Contractors)
Process Safety Total Incident Rate (#)
https://www.avient.com/sites/default/files/resources/PolyOne%25202017%2520Proxy%2520Statement.PDF
We currently anticipate that the shares requested in
connection with the approval of the 2017 Plan will last forff about three years, based on our historic grant rates and the
approximate current share price, but could last forff a shorter period of time if actual practice does not match historic
rates or our share price changes materially.
We provide long-term incentive compensation to our Named Executive Officers to
directly tie the interests of these individuals to the interests of our shareholders.
For purposes of
this table and threshold level disclosure, we assumed that the lowest weighted of the three perforff mance
measures achieved the threshold level of attainment (in other words, 7.5% of the target award was earned).
https://www.avient.com/sites/default/files/2021-10/avnt-q3-2021-news-release.pdf
We will be
sending out registration information shortly and will offer both in-person and virtual options in light
of the continuing impacts of the pandemic.”
Three Months Ended
September 30,
Nine Months Ended
September 30,
Reconciliation to Consolidated Statements of Income 2021 2020 2021 2020
Sales $ 1,219.8 $ 924.5 $ 3,617.3 $ 2,245.1
Gross margin - GAAP 255.4 210.2 846.5 531.4
Special items in gross margin (Attachment 3) 17.3 27.6 27.7 23.6
Adjusted gross margin $ 272.7 $ 237.8 $ 874.2 $ 555.0
Adjusted gross margin as a percent of sales 22.4 % 25.7 % 24.2 % 24.7 %
Operating income - GAAP 78.7 33.5 307.2 124.3
Special items in operating income (Attachment 3) 20.0 40.4 36.6 59.1
Adjusted operating income $ 98.7 $ 73.9 $ 343.8 $ 183.4
Adjusted operating income as a percent of sales 8.1 % 8.0 % 9.5 % 8.2 %
The table below reconciles pre-special income tax expense and the pre-special effective tax rate to their most comparable US
GAAP figures.
Three Months Ended September 30,
2021 2020
GAAP
Results
Special
Items
Adjusted
Results
GAAP
Results
Special
Items
Adjusted
Results
$ 61.1 $ 19.9 $ 81.0 $ 5.3 $ 50.0 $ 55.3
Income tax expense - GAAP (8.5) — (8.5) (2.7) — (2.7)
Income tax impact of special items (Attachment 3) — (4.6) (4.6) — (12.7) (12.7)
Tax adjustments (Attachment 3) — (3.6) (3.6) — 3.0 3.0
Income tax (expense) benefit $ (8.5) $ (8.2) $ (16.7) $ (2.7) $ (9.7) $ (12.4)
Effective Tax Rate(1) 14.1 % 20.8 % 51.9 % 22.7 %
(1) Rates may not recalculate from figures presented herein due to rounding
14
Nine Months Ended September 30,
2021 2020
GAAP
Results
Special
Items
Adjusted
Results
GAAP
Results
Special
Items
Adjusted
Results
$ 253.5 $ 36.5 $ 290.0 $ 81.6 $ 62.0 $ 143.6
Income tax expense - GAAP (51.8) — (51.8) (22.5) — (22.5)
Income tax impact of special items (Attachment 3) — (8.9) (8.9) — (15.4) (15.4)
Tax adjustments (Attachment 3) — (1.6) (1.6) — 4.9 4.9
Income tax (expense) benefit $ (51.8) $ (10.5) $ (62.3) $ (22.5) $ (10.5) $ (33.0)
Effective Tax Rate(1) 20.5 % 21.5 % 27.6 % 23.0 %
(1) Rates may not recalculate from figures presented herein due to rounding
The following pro forma adjustments are referenced by management to provide comparable business performance by
incorporating the Clariant Masterbatch business in periods prior to the acquisition date (July 1, 2020).